Cure My Disease

Don't miss your cure!

 Log in / Sign up

The relationship between digital health literacy and diabetes distress, diabetes Self-Management and HbA1c levels in individuals with type 2 diabetes

NCT ID NCT07888972

Sponsor: Abant Izzet Baysal University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Oct 22, 2026 · Last updated Oct 23, 2026 · Updated 1 time

Summary

This study aims to examine the relationships between digital health literacy, diabetes distress, diabetes self-management, and glycated hemoglobin (HbA1c) levels in individuals with type 2 diabetes mellitus (T2DM). The relationships between these variables will also be evaluated after controlling for relevant sociodemographic and clinical characteristics. The findings may contribute to a better understanding of factors associated with diabetes management and inform future nursing education and counseling interventions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 348 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population comprises adult patients (aged 18 years and older) clinically diagnosed with Type 2 Diabetes Mellitus for at least 6 months, receiving outpatient care at internal medicine and endocrinology clinics of hospitals in Bolu, Turkey. Eligible participants include individuals who voluntarily provide informed consent, possess sufficient literacy and communication capabilities to complete the study questionnaires, and have recorded HbA1c levels available from the past 3 months in their medical records. Data are collected from a non-probability convenience sample during routine follow-up visits.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years or older. * Diagnosed with type 2 diabetes mellitus by a physician at least 6 months prior to enrollment. * Able to read and write. * Able to communicate in Turkish and possess sufficient cognitive and communication abilities to understand and respond to the data collection instruments. * Have an HbA1c measurement obtained within the previous 3 months. * Willing to participate in the study voluntarily. Exclusion Criteria: * Having visual, hearing, cognitive, or communication impairments that prevent the participant from completing the data collection instruments. * Experiencing an acute diabetic complication during data collection or having a general health condition that prevents the participant from completing the data collection instruments.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 2 diabetes are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Type 2 diabetes

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Bolu Izzet Baysal State Hospital, BAIBU Training and Research Hospital

    Bolu, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.